相关实验视频
Updated: Apr 26, 2026

10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
9.4K
血液成分中的肝炎E病毒:英格兰东南部的流行率和传播研究
Patricia E Hewitt1, Samreen Ijaz2, Su R Brailsford3
1Transfusion Microbiology, National Health Service Blood and Transplant, London, UK.
Lancet (London, England)
|August 1, 2014
概括
肝炎E病毒 (HEV) 基因型3在英格兰普遍存在,每2848名献血者中有1名为病毒性肝炎. 输血传播不常见,但可以导致免疫抑制个体的持续感染.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 输血医学 输血医学
背景情况:
- 据怀疑,肝炎E病毒 (HEV) 基因型3在英格兰广泛传播,在聚合的血产品中检测到HEV.
- 之前的研究已追溯确定了HEV感染的捐赠者,但传播频率和结果尚不清楚.
- 英国人口和献血者中HEV基因型3的患病率需要进行调查.
研究的目的:
- 确定英格兰东南部献血中HEV RNA的流行率.
- 为了调查HEV通过血液成分传播的情况.
- 描述接受HEV污染血液成分的人的发病率和结果.
主要方法:
- 从2012年10月到2013年9月,对225,000次献血的HEV RNA进行了回顾性查.
- 使用血清学和基因组系学对HEV阳性捐赠的表征.
- 来自HEV病毒性捐赠的血液成分的接受者的鉴定和跟踪,以确定暴露结果.
主要成果:
- 在2848次捐献中,HEV RNA的流行率为1次,确定了79名病毒性捐献者.
- 大多数病毒性捐赠者是血清阴性;这些捐赠的129个成分中有62个在检测前被输血.
- 在43名接受者中,有18人 (42%) 显示出感染的迹象;免疫抑制影响了血清转换和病毒病持续时间,其中10人患上了持续性感染.
结论:
- 在英国人口和献血者中,HEV基因型3感染很普遍.
- 输血传播的HEV很少引起急性疾病,但可以导致免疫抑制患者的持续感染.
- 建议制定一项政策,用于识别和治疗持久的HEV感染,无论其来源如何,即使捐赠目前没有进行查.
相关概念视频
Hepatitis
78
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
78
Viral Hepatitis I: Introduction
21
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
21
Blood Transfusion and Agglutination
12.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.7K

